A Due
Posted Date: Sep 15, 2020
- Investigator: Jean Elwing
- Specialties:
- Type of Study: Drug
This is a study to assess the safety and efficacy of macitentan and tadalafil combination therapy compared to the respective monotherapies in subjects with pulmonary artery hypertension (PAH).
Criteria:
Adult Men And Women With Who Group 1 Pah In Who Fc Ii Or Iii May Be Eligible For This Research Study. Subjects Must Be Treatment Naïve Or On A Stable Dose Of Era Or Pde-5I Monotherapy. Additional Eligibility Criteria Are Required To Participate. Please Co
Keywords:
Pulmonary Hypertension, Era, Pde-5 Inhibitor
For More Information:
Jessica Anderson
5135583077
ander5ja@ucmail.uc.edu